版本:
中国

BRIEF-Trillium announces pricing of U.S.$30.0 mln public offering of common shares

May 26 Trillium Therapeutics Inc:

* Trillium announces pricing of U.S.$30.0 million public offering of common shares and series II non-voting convertible first preference shares

* Trillium Therapeutics Inc - priced its public offering of 2.8 million common shares and 3.3 million series II non-voting convertible first preferred shares

* Trillium Therapeutics Inc - common shares are being sold at a public offering price of U.S.$5.00 per share

* Trillium Therapeutics Inc - series II non-voting convertible first preferred shares are being sold at a public offering price of U.S.$5.00 per share Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐